Consulting Services in relation to Medical Device Development under Blueprint MedTech Initiative – Subject Matter Expert in Medical Device Investment Development

Award Notice Posted

Solicitation number
75N95025P00045
Agency
Awarded
to Sattva Science, LLC
Set-aside
Woman-Owned Small Business Sole Source

Opportunity facts

Contract number
75N95025P00045 Federal contract award
Place of performance
20892, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a contract (No. 75N95025P00045) to SATTVA SCIENCE, LLC for consulting services related to medical device development under the Blueprint MedTech Initiative. The contract is a time and materials/labor hour agreement with a base period of twelve months and two twelve-month option periods, initially funded at $11,700.00 with a potential total contract value of $70,200.00 if all options are exercised. As a woman-owned small business sole source award, the contract will provide subject matter expertise and technical guidance on medical device investment development to NIH program leadership. The solicitation (75N95025Q00018) was specifically targeted at supporting the Office of Translational Initiatives and Program Innovations (OTIPI) and was awarded on December 6, 2024.

Notice text

On December 6, 2024; in response to the requirements of Solicitation 75N95025Q00018, the National Institute on Drug Abuse (NIDA) awarded a Contract No. 75N95025P00045 to SATTVA SCIENCE, LLC as a time and materials/labor hour contract with a base period of twelve months and two twelve-month option periods, plus option quantities. At the time of award, the contract was funded in the not-to-exceed amount of $11,700.00. If all options are exercised, the total contract and obligated amount shall not exceed $70,200.00.

Awarded contract 75N95025P00045 to SATTVA SCIENCE, LLC for 70200.00 on 2024-12-06.

Files

File Type Posted
SSJ Sattva Redacted.pdf PDF

Similar open opportunities

Opportunity Agency Set-aside Responses due
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse Total Small Business
Synthesis and Distribution of Drugs of Abuse and Related Compounds NAICS 541715 National Institute on Drug Abuse No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors